Most pre-COVID telemed visits deemed appropriate across 5 specialties

As the COVID crisis nudges patients as well as providers to give telemedicine a try, a new study shows the option may have had momentum even if the pandemic hadn’t happened.

Looking at more than 6,500 e-consults made by 1,100 referring providers to 121 specialists—all of which took place by November 2018—researchers found more than 70% of the virtual visits met four key appropriateness criteria.

The criteria were that the clinical inquiries had to have been suitably urgent and fittingly complex while not being answerable by reviewing evidence-based summary sources or by merely requesting logistic information.

Meanwhile expert raters agreed on the appropriateness of the completed e-consults 94% of the time, according to the study abstract as published online April 14 in Annals of Internal Medicine.

In addition, the overall rate of avoided visits across the five specialties in the study—hematology, infectious disease, dermatology, rheumatology and psychiatry—topped 80% overall.

The highest rate of avoided visits was seen in psychiatry (92.6%), the lowest in dermatology (61.9%).

Researchers drew the cases from primary and specialty care practices at two large academic medical centers and two community hospitals in an integrated health system.

Lead author Salman Ahmed, MD, MPH, of Brigham and Women’s Hospital and colleagues comment that their novel metrics to assess the appropriateness and utility of e-consults “provide meaningful insight into practice, provide a rubric for comparison in future studies in additional settings, and suggest areas to improve resource use and patient care.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty. 

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue.